Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Current Leases (2017 - 2025)

Bioceres Crop Solutions' Current Leases history spans 8 years, with the latest figure at $6.9 million for Q2 2025.

  • For Q2 2025, Current Leases rose 120.45% year-over-year to $6.9 million; the TTM value through Jun 2025 reached $6.9 million, up 120.45%, while the annual FY2025 figure was $6.9 million, 120.45% up from the prior year.
  • Current Leases for Q2 2025 was $6.9 million at Bioceres Crop Solutions, up from $3.1 million in the prior quarter.
  • Across five years, Current Leases topped out at $6.9 million in Q2 2025 and bottomed at $750308.0 in Q2 2021.
  • The 5-year median for Current Leases is $3.1 million (2024), against an average of $3.2 million.
  • The largest annual shift saw Current Leases soared 173.1% in 2023 before it dropped 19.07% in 2024.
  • A 5-year view of Current Leases shows it stood at $750308.0 in 2021, then surged by 88.31% to $1.4 million in 2022, then skyrocketed by 173.1% to $3.9 million in 2023, then decreased by 19.07% to $3.1 million in 2024, then skyrocketed by 120.45% to $6.9 million in 2025.
  • Per Business Quant, the three most recent readings for BIOX's Current Leases are $6.9 million (Q2 2025), $3.1 million (Q2 2024), and $3.9 million (Q2 2023).